WILMINGTON, MASSACHUSETTS — Cantor Fitzgerald raised its price target on Analog Devices, Inc. to $550 from $510 on June 29, 2026, while maintaining an Overweight rating on the shares. The firm cited the accelerating buildout of artificial intelligence infrastructure as the beginning of a generational semiconductor investment cycle.
Cantor Fitzgerald projected industry revenue to reach approximately $3 trillion by calendar year 2029. The firm further indicated that industry revenue could potentially exceed $3.5 trillion by 2030.
On June 24, 2026, Stifel increased its price target on Analog Devices, Inc. to $498 from $450. Stifel reiterated a Buy rating for the company's shares.
Stifel stated that its thesis for a breakout year for analog semiconductor companies in 2026 had been validated. This assessment followed stronger-than-expected results from several chipmakers focused on artificial intelligence.
Analog Devices, Inc. was founded in 1965 and is headquartered in Wilmington, Massachusetts. The company designs high-performance semiconductor chips and software.
These products are used across various applications including industrial, automotive, communications, healthcare, and energy sectors. Analog Devices also develops advanced battery management technologies for rechargeable battery systems found in electric vehicles and energy storage applications.
Why It Matters
These adjustments in price targets and ratings reflect an industry outlook that anticipates growth driven by artificial intelligence infrastructure. The projections from Cantor Fitzgerald suggest an increase in semiconductor industry revenue over the next few years, pointing to a period of expansion.
The validation of Stifel's thesis by results from AI-focused chipmakers indicates that the reported growth trends extend beyond a single company, affecting the broader analog semiconductor market. Analog Devices' role in diverse sectors, including electric vehicles and energy storage, positions it within this expanding technological landscape.
forum Comments (0)
No comments yet. Be the first to comment.